You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment

 

Online download statistics by month:

Online download statistics by month: March 2020 to April 2026

AbstractFullPdf
Mar 2020331
Apr 202020200
May 202018181
Jun 2020991
Jul 2020440
Aug 2020323224
Sep 2020373716
Oct 2020979729
Nov 2020444425
Dec 2020535310
Jan 2021636220
Feb 2021484826
Mar 2021818124
Apr 2021656528
May 2021434338
Jun 2021545428
Jul 2021595941
Aug 2021484832
Sep 2021707055
Oct 2021565649
Nov 2021858358
Dec 2021808352
Jan 2022576319
Feb 2022424637
Mar 2022414520
Apr 2022454821
May 2022393944
Jun 2022525627
Jul 2022475027
Aug 2022646936
Sep 20229910533
Oct 2022718342
Nov 2022484922
Dec 2022434316
Jan 2023606025
Feb 2023676744
Mar 2023747420
Apr 2023636540
May 2023404026
Jun 2023434320
Jul 2023464625
Aug 2023353616
Sep 2023363612
Oct 2023585833
Nov 2023606124
Dec 2023353523
Jan 2024889033
Feb 2024737328
Mar 2024535451
Apr 2024545732
May 2024525327
Jun 2024555634
Jul 2024535326
Aug 2024383825
Sep 2024363626
Oct 2024474794
Nov 2024606843
Dec 2024737326
Jan 2025585834
Feb 2025798158
Mar 2025686858
Apr 2025727242
May 2025787888
Jun 2025535358
Jul 2025220
Aug 2025110
Apr 2026110
Total342834981993